TABLE 2.
Baseline |
After crossover |
|||
---|---|---|---|---|
MM (n = 249) |
Placebo (n = 251) |
MM (n = 156) |
Placebo (n = 141) |
|
Age (y) | 34.2 ± 132 | 34.2 ± 13 | 35.8 (13.9) | 36.6 (13) |
Male (n) | 79 | 83 | 54 | 49 |
Female (n) | 170 | 168 | 102 | 92 |
Education [n (%)] | — | — | — | — |
No secondary | 185 (74) | 193 (77) | 119 (76) | 107 (76) |
Any secondary | 64 (26) | 58 (23) | 37 (24) | 34 (24) |
Poor housing (ie, domestic hygiene score below median) [n (%)] | 83 (51) of 164 scored | 86 (57) of 151 scored | 47 (38) of 124 scored | 38 (32) of 119 scored |
BMI (kg/m2) | 22.5 ± 4.4 | 22.5 ± 4.6 | 24 ± 5.5 | 23.2 ± 4.5 |
MUAC (cm) | 26.7 ± 3.8 | 26.9 ± 3.8 | 28.8 ± 4 | 27.7 ± 3.7 |
HIV positive [n (%)] | 69/169 tested (41) | 67/191 (35) | 57/134 (43) | 54/124 (44) |
CD4 count | 370 ± 190 | 365 ± 212 | 415 ± 242 | 409 ± 192 |
Household (cluster) size3 | ||||
1 participant | 49 | 48 | — | — |
2 participants | 67 | 67 | — | — |
3 participants | 10 | 11 | — | — |
4 participants | 4 | 4 | — | — |
5 participants | 4 | 4 | — | — |
Statistical testing of all these factors by either t test or chi-square test showed no difference in treatment allocation groups. MM, multiple micronutrient supplementation group.
Mean ± SD (all such values).
Baseline only.